Albemarle Corp diskutieren
Albemarle Corp
WKN: 890167 / Symbol: ALB / Name: Albemarle / Aktie / Chemie / Mid Cap /
113,72 €
-0,19 %
Albemarle Corporation (NYSE: ALB) was downgraded by analysts at UBS Group AG from a "hold" rating to a "sell" rating. They now have a $57.00 price target on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Corporation (NYSE: ALB) was downgraded by analysts at Robert W. Baird from a "neutral" rating to an "underperform" rating. They now have a $60.00 price target on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle Corporation (NYSE: ALB) had its price target raised by analysts at UBS Group AG from $57.00 to $62.00. They now have a "sell" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle (NYSE:ALB) had its price target raised by analysts at Robert W. Baird from $58.00 to $68.00. They now have an "underperform" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle (NYSE:ALB) had its price target raised by analysts at Jefferies Financial Group Inc. from $90.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle (NYSE:ALB) had its price target raised by analysts at Royal Bank Of Canada from $80.00 to $117.00. They now have an "outperform" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle (NYSE:ALB) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $135.00 price target on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle (NYSE:ALB) had its price target raised by analysts at Dbs Bank from $100.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle (NYSE:ALB) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.
Ratings data for ALB provided by MarketBeat
Albemarle (NYSE:ALB) had its price target raised by analysts at Robert W. Baird from $68.00 to $81.00. They now have an "underperform" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle (NYSE:ALB) had its price target raised by analysts at Royal Bank Of Canada from $117.00 to $120.00. They now have an "outperform" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle (NYSE:ALB) had its price target raised by analysts at Argus from $120.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle (NYSE:ALB) had its price target raised by analysts at Rothschild & Co Redburn from $135.00 to $158.00. They now have a "buy" rating on the stock.
Ratings data for ALB provided by MarketBeat
Albemarle (NYSE:ALB) had its price target raised by analysts at Jefferies Financial Group Inc. from $124.00 to $152.00. They now have a "buy" rating on the stock.
Ratings data for ALB provided by MarketBeat
Neueste Beiträge
Royal_Bank_of_Canada in Arrowhead Pharmaceuticals Inc. diskutieren